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INThODUCTION
In a recent publication (1), we reported our observations on
the relative physiological properties of certain dialkyl and
trialkyl barbituric acids. We concluded on the basis of our
animal experiments that the following dialkyl compounds p08-





Of the trialkyl barbituric acids, there proved to be but one
member which possessed properties worthy of consideration,
namely, the 1-methyl-5 ,5-ethyl-n-butyl compound. In general,
the introduction of an alkyl group at position number 1 of
5 ,5-dialkyl barbituric acids failed to enhance the anesthetic
action of the parent dialkyl compound. The present paper
reports the results of further investigations of the anesthetic po-
tency of 5, 5-dialkyl barbituric acids and of a series of barbituric
acid derivatives containing in addition to the dialkylation at
position 5 of the pyrimidine ring an aryl instead of an alkyl group
at position 1.
CHEMICAL CONSIDERATION
The first group under discussion contains fourS, -disubstituted
barbituric acids on which physiological tests have not previQusly
been reported. The ethyl-n-amy!, di-n-amyl and ethyltetra-
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hydrofurfuryl derivatives have recently been described by Dox
and Jones (2). The dibenzyl derivative was prepared by Fischer
and Dilthey (3) but not included in the series of tests performed
by Fischer and v. Mering (4). Shonle and Moment (5) report it
as ineffective in a dose of 0.5 gram per kilogram to rabbits.
Of the 1-aryl-S ,S-dialkylbarbituric acids considered in table 2
only the first member, the phenyl derivative, has been previously
described. It was prepared by Fischer and Dilthey (3) who
reported a melting point of 197#{176}. Despite repeated recrystalliza-
tions from various solvents the melting point of our product re-.
mained constant at 177#{176}.More recently the same derivative has
been prepared by Pfeiffer and Seydel (6) who also report a melt-
ing point of 177#{176}.
For the preparation of the 1-aryl-5 ,5-dialkyl barbituric acids
the method employed was the condensation of the ethyl dial-
kylmalonate with the appropriate arylurea in the presence of
sodium ethoxide in absolute alcohol. The method is too well
known to require detailed description. it is interesting to note
that in general the N-aryl derivatives thus obtained have higher
melting points than the series of N-alkyl derivatives described
in our previous paper. It is of interest also to note that the
p-ethoxy-phenyl derivative prepared from p-ethoxyphenylurea,
the powerful sweetening agent known as “Dulcin,” is entirely
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The failure to obtain the 1-phenyl-5 ,5-ethyl-n-butyl derivative
in crystalline form is rather puzzling. We attempted this
preparation four separate times using different preparations of
the malonic ester and carefully purified phenylurea. A trans-
parent gummy mass was invariably obtained. Despite the close
agreement of the nitrogen content of the product with the value
calculated from the formula, the possibifity remains that im-
purities may have been present. No other member of the series
presented any serious difficulty in crystaffization.
Other products mentioned in this paper, but of more or less
incidental interest, are 1 ,3-diphenyl-5-ethylbarbituric acid and
the p-ethoxyphenylmonoureide of ethyl-n-butylmalonic acid.
The first was prepared by condensation of ethylmalonic acid
with carbanilide in the presence of phosphorus oxychioride.
Crystallized from alcohol it melted at 145#{176}and contained 9.23
per cent nitrogen; calculated for C18H1603N2, 9.09 per cent.
The second was a product of hydrolysis obtained in attempting
to prepare 1-p-ethoxyphenyl-5 ,S-ethyl-n-butyl barbituric acid.
It melted at 124-5#{176}with evolution of gas. It contained 8.20
per cent nitrogen; calculated for C18H2603N2, 8.00 per cent.
The loss in weight when melted was 12.58 per cent; calculated
for 1 C02, 12.57 per cent. The melted product solidified on
cooling and after recrystaffization from dilute alcohol melted
again at 78#{176}.Further identification and examination of its
properties was not attempted.
PHYSIOLOGICAL CONSIDERATION
In the recent publication referred to above, we employed both
rabbits and mice in studying the relative merits of the barbituric
acid derivatives. We found that the results in these two animals
paralleled each other so closely that it was unnecessary to employ
both. Mice of 15 to 20 grams body weight have proven to be
very satisfactory for the purpose of studying the relative hypnotic
actions on the basis of relative anesthetic effects. Throughout
the present work, therefore, mice only have been employed.
The barbituric acid compounds were in each instance dissolved
in a slight excess of sodium hydroxide just before using, and were
invariably administered intraperitoneally.
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The new members of this series subjected to the tests were
5,5-ethyl-n-amyl barbituric acid
5,5-di-n-amyl barbituric acid
5 ,5-ethyl-tetrahydrofulfuryl barbituric acid
5,5-dibenzyl barbituric acid
For the purpose of control, every time mice were employed for
the tests, 5 ,5-ethyl-iso-amyl barbituric acid was administered
to a sufficient number to ascertain their uniformity of response.
Over a period of a year these animals which were kept on a
constant diet of bread, dog biscuit and carrots responded in a
remarkably uniform manner to this drug. The minimum anes-
thetic dose ranged from 65 to 75 mgm. per kilogram of body
weight and the minimum lethal dose was between 180 and 190
mgm.
In table 1 are given the observations made with these barbituric
acid derivatives. For the sake of comparison 5 ,5-ethyl-isoamyl
barbituric acid is included in the table.
An examination of table 1 shows that 5, 5-ethyl-n-amyl
barbituric acid is almost identical in potency and action with its
iso-isomer. 5 ,5-di-n-amyl barbituric acid is not as potent as the
above, and it induces a symptom complex in which paraplegia is
prominent. We have attributed this series of symptoms to the
influence of high molecular weight, but this is by no means in-
variable. S ,5-ethyl-tetrahydrofurfuryl barbituric acid also
causes paraplegia, but does not induce complete anesthesia even
in doses up to 700 mgm. per kilogram of body weight. The
S , 5-dibenyl compound induces anesthesia only in amounts
almost as large as the minimum lethal dose. It also causes re-
peated clonic convulsions. The anesthesia resembles that in-
duced by 5, 5-diethyl barbituric acid in being attended by fine
generalized tremors. In this series, then, only one preparation
possesses properties comparable to those of the most satisfactory
5 ,5-dia!kyl derivatives described in the introduction.
1-ARYL-5 , 5-DIALKYL BARBITURIC ACIDS
During the course of our tests with these compounds, S ,5-
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the responsiveness of the mice. This series of preparations con-
tains only one heretofore known barbituric acid derivative,
namely, 1-phenyl-5 ,S-diethyl barbituric acid which was prepared
but not tested by Fischer and Dilthey (3). The list is given on
a previous page. An attempt to synthesize 1-p-ethoxyphenyl-
5 ,5-ethyl-n-butyl barbituric acid resulted in the formation of
p-ethoxy-phenyl-monoureide of ethyl-n-butyl malonic acid. This
compound was also tested, but as it is not a true member of the
above series, results with it will be recorded later in this article.
The above series of 1-aryl-5 ,5-dialkyl compounds was tested
and the individual and comparative data are recorded in table 2.
An analysis of the comparative results recorded in table 2
reveals some interesting facts. None of the 1-aryl derivatives
of S , 5-diethyl barbituric acid possesses properties worthy of
mention. In this particular group the radicals attached to posi-
tion 5 were kept constant and those attached to position 1 were
varied. See formula III below. Under these conditions the
methyl, methoxy, ethoxy, bromo and chioro groups in para
position to the carbon attached to position number 1 of the
barbituric acid ring fail to introduce any noteworthy properties.
Halogens ordinarily increase the potency of anesthetics when
introduced in chemical combination with them. Such is not the
case in this series. Most of these derivatives are less toxic than
their parent dialkyl compound and even than their 1-phenyl-
5 ,5-cliethyl parent, but as anesthetics they are of no value.
In contradistinction to the above group of the series, the re-
maining members have the radical attached to number 1 con-
stant, and one of the two alkyl radicals combined at position
number 5 replaced by a higher member of the aliphatic series.
(See formula II below.) For sake of clarity the following struc-
tural formula may be of assistance,
I II III
(6) C-N (1) O=C-N-R” O=C-N-R”
I I R\I I R\I I
(5)C C(2) )C C=O )C 0=0
I I R’71 I R71
(4) C-N (3) 0=0-NH 0=0-NH
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(Formula I illustrates the positions in the barbituric acid ring numerically.
In formula II R represents the ethyl group, R’ a higher aliphatic group and R”
the phenyl radical. Members with this type of structure are discussed below.
In formula III R shows that the alkyl groups at position number 5 are the same,
and R” represents the phenyl radical or substituted phenyl groups which there-
fore illustrates the members of the series discuseed above wherein the aryl
group at position number I is varied.)
This group of members is the most interesting in the series.
They are the 1-phenyl derivative of S ,S-ethyl-n-propyl-, S ,5-
ethyl-n-butyl-, 5 , 5-ethyl-isobutyl-, and 5 , 5-ethyl-isoamyl- barbi-
turic acids. In general, the introduction of the phenyl radical
at position number 1 of the barbituric acid ring decreases the
toxicity of the parent 5 , 5-dialkyl compound in this group.
This results in an increased M.A.D. : M.L.D. ratio, a desirable
quality. The M.L.D. 15 invariably higher, and the M.A.D. is lower
in the case of the 1-phenyl-5 ,5-ethyl-n-butyl compound, and
higher in the case of its iso-isomer. The most commendable
member is the 1-phenyl-5 ,5-ethyl-n-butyl barbituric acid for it
has an M.A.D. to M.L.D. ratio of about 1 to 15. One drawback
to its employment is the fact that it is the only member of table 2
which has remained refractory to crystallization. It was ob-
tamed as a thick syrup which is difficult to dissolve in sodium
hydroxide.
With few exceptions the compounds in table 2 cause a very
pronounced preanesthetic excitement in mice. This, however, is
not seen in rabbits. Those not inducing excitement cause a pre-
anesthetic paraplegia. That this symptom is not entirely due
to high molecular weight is well illustrated by the two isomers
1-phenyl-5 , 5-ethyl-.n-butyl and 1-phenyl-5 ,5-ethyl-isobutyl barbi-
turic acid, the former of which causes preanesthetic excitement
and the latter preanesthetic paraplegia.
There is a possibility that the above derivatives may have
analgesic properties in doses lower than anesthetic, for the phenyl
group attached to a nitrogen of the barbituric acid radical simu-
lates the structure of anilides. However, this phase of the work
will not be considered at the present time.
164 AXEL M. HJORT AND ARTHUR W. DOX
MISCELLANEOUS BARBITURIC ACID DERIVATIVES
We examined two compounds which do not fall in the two
series above described. These are 1 ,3-diphenyl-S-ethyl barbi-
turic acid and p-ethoxy-phenyl-monoureide of ethyl-n-butyl-
malonic acid. Both of these proved to be inert from the stand-
point of anesthetic action. The latter proved lethal in doses of
300 mgm. per kilogram of body weight and no signs of anesthesia
were observed in doses up to 600 mgm. Death was usually
sudden after signs of violent excitement of a few moments dura-
tion. The former was devoid of any observable action in doses
up to 750 mgm. per kilogram of body weight.
CONCLUSIONS
1 . S , S-ethyl-n-amyl barbituric acid possesses properties which
place it in the group of dialkyl derivatives the members of which,
from animal experiments, are recommended as best for thera-
peutic employment.
2. The 1-aryl derivatives of S , 5-diethyl barbituric acid here
investigated have no virtues worthy of recommendation.
3. The 1-phenyl derivatives of 5 ,5-ethyl-n-propyl, 5 ,S-ethyl-
n-butyl, 5 , 5-ethyl-isobutyl and 5 , 5-ethyl-isoamyl barbituric acids
are almost uniformly more effective anesthetics than their S , S
dialkyl parent compounds. The introduction of the phenyl
group at position 1 of these S , S-dialkyl barbituric acids decreases
their toxicity and improves their M.A.D. M.L.D. ratio.
4. Opening the barbituric acid ring or leaving one of the
hydrogens at position 5 unsubstituted results in the loss of hyp-
notic action.
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